OneMedNet Corporation

ONMD Healthcare Health Information Services

OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024.

Revenue
+88.4%
EPS
−157.1%
Free cash flow
+14.1%
Total debt
+75.3%

Quarter to June 2026, against a year earlier

5.14 0.97 +23.26%
Market cap
$25.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
−77.91
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 4.19
Sold, $m 0.10
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — 1 — 1 1 5 1 — 1 2 —
Sell — — — — — — — — — 2 — —
Insider Ownership 70.18%

Capital & Financial Ratios $m

Size
Market Cap 25.08
Revenue ttm 1.46
Net income ttm (8.51)
Free cash flow ttm (6.89)
Net debt Q 0.34
Valuation
P/E 0.00
Forward P/E —
Price / sales 16.83 (above 10: high)
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 0.28 (below 1: weak)
Debt / equity Q (0.20) (negative: negative equity)
Interest coverage Q (251.22)
Growth
Revenue growth Q +88.39% (above 0%: growing)
Operating income growth Q −9.60% (below 0%: shrinking)
EPS, this year —
EPS, next year A —
Revenue, next year A —
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 3 1 0
Receivables 0 0 0 1
Inventory — — — —
Other — — — —
0 4 2 1
2023 2024 2025 Q'26
Payables 5 6 3 3
ST’ Debt 3 4 1 1
Other 4 3 0 —
14 19 5 5

Compound Annual Growth %

10y 5y 3y
Sales — — 5.63%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

EPS $

Mar Jun Sep Dec Year
’26 (0.40) (0.40) — — —
’25 (0.60) 0.70 (0.14) (0.70) (0.60)
’24 (0.90) (1.50) (0.70) (0.50) (3.60)
’23 (19.40) (23.81) (32.33) (1.49) (46.46)
’22 6.34 0.60 (0.44) (85.27) (76.63)
’21 0.00 10.20 0.90 — 15.58
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 0 0 — — —
’25 0 0 0 1 1
’24 0 0 0 0 1
’23 0 0 0 0 1
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (2) — — —
’25 (2) (2) (2) (2) (8)
’24 (2) (2) (2) (2) (7)
’23 (1) (1) (1) (2) (5)
’22 0 0 0 (4) (5)
’21 — (1) 0 0 0
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (2) — — —
’25 (2) (2) (2) (2) (8)
’24 (2) (2) (2) (2) (7)
’23 (1) (1) (1) (2) (5)
’22 0 0 0 (4) (5)
’22 — — — — (1)
’21 — (1) 0 0 0
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — 1 1 1 1 1 +5.6% — — — —
Gross margin, % — — — — — — (31.22) (12.63) (43.70) (37.01) (67.56) (5.8) pt
EBT — — — — — 5 (30) (34) (10) (3) (9) n/m
EBT margin, % — — — — — 0.00 (2,639.55) (3,306.76) (1,574.96) (206.03) (584.54) (206.0) pt
Net income — 0 — — — 5 (30) (34) (10) (3) (9) n/m
Per share, $
Per share, $ Revenue — — — — — 0.00 2.90 1.40 0.23 0.31 0.25 n/m
Earnings — — — — — 15.58 (76.63) (46.46) (3.60) (0.60) (1.64) n/m
Cash flow — — — — — (1.15) (11.83) (6.59) (2.48) (1.68) (1.19) +10.0%
Capex — — — — — 0.00 (0.15) (0.06) (0.02) 0.00 0.00 n/m
Free cash flow — — — — — (1.15) (11.98) (6.65) (2.49) (1.69) (1.19) +10.1%
Book value — — — — — (26.12) (66.33) (18.49) (5.68) (0.67) (0.61) (60.0%)
Shares, m — — — — — 0 0 1 3 4 5 +91.7%
Valuation, ×
Valuation, × P/E — — — — — — 0.00 0.00 0.00 0.00 0.00 0.0
P/S — — — — — — 0.00 5.28 59.39 36.06 16.83 25.2
P/B — — — — — — 0.00 0.00 0.00 0.00 0.00 0.0
EV/Sales — — — — — — 0.00 9.07 63.06 35.97 17.06 27.0
EV/FCF — — — — — — (9.08) (1.89) (5.79) (6.50) (3.60) (5.8)
Cash, $m
Cash, $m Operating cash flow — — — — — 0 (5) (5) (7) (8) (7) +111.0%
Capex — — — — — — 0 0 0 0 0 (39.3%)
Free cash flow — — — — — 0 (5) (5) (7) (8) (7) +111.1%
Balance, $m
Balance, $m Working capital — — — — — 0 (26) (13) (16) (3) (3) n/m
Net debt — — — — — 0 1 3 1 0 0 (28.7%)
Shareholders’ equity — — — — — (9) (26) (13) (16) (3) (4) (23.4%)
Returns, %
Returns, % ROA — — — — — 4.36 (51.12) (3,853.96) (483.37) (95.30) (459.66) (99.7) pt
ROIC — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.0 pt
ROE — — — — — 10.26 115.76 117.61 68.92 29.62 231.20 +19.4 pt
People
People Employees — — — — — 2 2 20 24 23 — +84.2%
Revenue/emp, $m — — — — — 0.00 0.58 0.05 0.03 0.06 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Nov 2026

OneMedNet Corporation vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HCAT Health Catalyst, Inc. $112.9M — (loss-making) — (loss-making) −26.26% (below 0%: shrinking) n/m +65.58% (above 0%: growing) 42.71% 89.08% Compare
LFMD LifeMD, Inc. $110.4M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
CCLD CareCloud, Inc. $91.8M 16.5× 11.0× +8.56% (above 0%: growing) +150.00% (above 0%: growing) −0.44% (below 0%: shrinking) 50.46% 19.50% Compare
DRIO DarioHealth Corp. $26.7M — (loss-making) — (loss-making) −3.58% (below 0%: shrinking) n/m −0.74% (below 0%: shrinking) 61.66% (125.15%) Compare
ONMD OneMedNet Corporation $25.1M — (loss-making) — +88.39% (above 0%: growing) n/m +14.05% (above 0%: growing) (193.49%) (774.32%)
BEAT HeartBeam, Inc. $22.2M — (loss-making) — — n/m −1.24% (below 0%: shrinking) — 0.00% Compare
RNLXY Renalytix plc - Sponsored ADR $17.2M — (loss-making) — +13.73% (above 0%: growing) n/m +17.96% (above 0%: growing) 19.16% (783.91%) Compare
BFRG Bullfrog AI Holdings Inc. $9.1M — (loss-making) — (loss-making) +2,054.00% (above 0%: growing) n/m −5.67% (below 0%: shrinking) 49.63% (658.82%) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
Median of peers $24.5M — — −3.55% — −0.59% 49.63% (70.11%)

All 44 Health Information Services stocks →

Pay and ownership Proxy statement filed 19 August 2026

Ownership

Directors and executive officers, together 50.20%
Dr. Thomas Kosasa 31.30%
Dr. Jeffrey Yu 14.70%
James Sixsmith 8.70%
Data Knights LLC 5.80%
Off the Chain, LP 5.40%
TD Securities (USA) LLC 5.10%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

OneMedNet Corporation (ONMD) Latest News

25 Sep

Impact 3 · · GlobeNewswire

12 Feb

Impact 4 · · GlobeNewswireInsider MonkeyInsider MonkeySimply Wall St.Insider MonkeyZacksZacks

10 Dec

28 Nov

Impact 3 · · Associated Press Finance

24 Nov

16 Oct

stockrow.com/ONMD · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com